TD Asset Management’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-6,130
Closed -$223K 1361
2020
Q1
$223K Buy
+6,130
New +$228K ﹤0.01% 1305
2018
Q4
Sell
-14,433
Closed -$742K 1410
2018
Q3
$742K Buy
14,433
+152
+1% +$7.61K ﹤0.01% 1219
2018
Q2
$719K Buy
14,281
+221
+2% +$11.2K ﹤0.01% 1198
2018
Q1
$718K Buy
14,060
+414
+3% +$22.1K ﹤0.01% 1131
2017
Q4
$717K Buy
13,646
+538
+4% +$26.7K ﹤0.01% 1129
2017
Q3
$641K Buy
+13,108
New +$623K ﹤0.01% 1131
2014
Q2
Sell
-7,800
Closed -$272K 1298
2014
Q1
$272K Sell
7,800
-55,596
-88% -$1.95M ﹤0.01% 1178
2013
Q4
$2.26M Buy
63,396
+65
+0.1% +$2.18K ﹤0.01% 790
2013
Q3
$2.05M Buy
63,331
+741
+1% +$24.1K ﹤0.01% 797
2013
Q2
$2.21M Buy
+62,590
New +$2.18M ﹤0.01% 751

Other funds holding FMS

TD Asset Management's FMS Position: Q2 2020 in Review

TD Asset Management sold out of Fresenius Medical Care (FMS) in Q2 2020, closing a stake of 6,130 shares — an estimated $223K sold.

TD Asset Management first reported a position in FMS in Q2 2013 and held it in 10 quarters. The position peaked at $2.26M in Q4 2013. 179 funds tracked by Wall St. Rank hold FMS as of Q2 2020.

  • TD Asset Management reported no remaining Fresenius Medical Care position as of Q2 2020 after selling out during the quarter.
  • TD Asset Management sold 6,130 Fresenius Medical Care shares in Q2 2020, an estimated $223K.
  • TD Asset Management first reported a position in Fresenius Medical Care in Q2 2013 and held it in 10 quarters.
  • TD Asset Management's Fresenius Medical Care position peaked at $2.26M in Q4 2013.
  • 179 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2020.

Based on TD Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.